Kara Mari De Felice , MD

Bachelor's Degree: McNeese State University Lake Charles, LA, 2005 ((Chemistry and Biology))

Medical Degree: Tulane University School of Medicine New Orleans, LA, 2009

Internal Medicine Residency: Johns Hopkins University Baltimore, MD, 2012

Gastroenterology Fellowship: Mayo Clinic Rochester, MN, 2015

American Board of Internal Medicine (Gastroenterology) (Certification Date: 11-10-2015 )

Gastroenterology

Crohn's Disease

Ulcerative Colitis

Digestive Diseases

Internal Medicine

2015 -2021 Assistant Professor of Medicine, Department of Gastroenterology, Louisiana State University, New Orleans, LA

2015 -2021 Director of Inflammatory Bowel Disease, Department of Gastroenterology, Louisiana State University, New Orleans, LA

2021 - Associate Professor of Medicine, Department of Digestive Diseases, University of Cincinnati, Cincinnati, OH

2021 - Director of Inflammatory Bowel Disease Clinic, Department of Digestive Diseases, University of Cincinnati, Cincinnati, OH

Grant: #20523_878246 Investigators:De Felice, Kara 01-01-2022 -12-31-2022 Crohn's & Colitis Foundation of American A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and persistence with Inflammatory Bowel DIsease MedIcal Therapy - ASSIST Study Role:PI 6710.00 Hold Level:Non Profit

Grant: #STOMP-II Investigators:De Felice, Kara 05-01-2023 -04-03-2026 Avobis Bio, LLC Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II) Role:PI 0.00 Hold Level:Industry

Grant: #SPARC IBD Site Agreement Investigators:Brook, Loren; De Felice, Kara; Reynolds, Gorman; Yacyshyn, Bruce 07-13-2018 -07-12-2024 Crohn's & Colitis Foundation of American Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD) Role:PI 256060.34 Active Level:Non Profit

Grant: #M24-885 Investigators:De Felice, Kara 08-23-2024 -08-23-2028 AbbVie, Inc. A Phase 2a Multicenter, Randomized, Platform Study of Targeted Therapies for the Treatment of Adult Subjects with Moderate to Severe Crohn's Diseas Role:PI 0.00 Hold Level:Industry

Grant: #1447-0012 Investigators:De Felice, Kara 11-07-2024 -11-17-2029 Takeda Development Center Americas, Inc. An Open-Label, Phase 4, Single-Arm, Multicenter Study to Evaluate the Induction of Response and Remission of Vedolizumab Dual Targeted Therapy with Tofacitinib in Adult Patients with Moderately to Sev Role:PI 0.00 Hold Level:Industry

Grant: #Vedolizumab-4051 Investigators:De Felice, Kara 02-12-2024 -02-12-2029 Alimentiv An Open-Label, Phase 4, Single-Arm, Multicenter Study to Evaluate the Induction of Response and Remission of Vedolizumab Dual Targeted Therapy with Tofacitinib in Adult Patients with Moderately to Sev Role:PI 326437.56 Hold Level:Industry

Investigators:De Felice, Kara 02-12-2024 -02-12-2029 Alimentiv An Open-Label, Phase 4 Study to Evaluate the Efficacy and Safety of Dual Targeted Therapy with Vedolizumab Intravenous (IV) and Adalimumab Subcutaneous (SC) or Vedolizumab IV and Ustekinumab IV/SC in Role:PI 326437.56 Hold Level:Industry

Peer Reviewed Publications

De Felice, Kara Mari (2020. ) Patients Perception of Risks and Benefits of Biologic Therapy.Inflammatory bowel diseases, , 26 (1 ) ,147-149 More Information

Nakanishi, Yukihiro; Jetly-Shridhar, Rachna; De Felice, Kara (2019. ) A Case of Pseudomelanosis Duodeni: Striking Endoscopic Features With Subtle but Characteristic Pathologic Findings.International journal of surgical pathology, , 27 (7 ) ,765-766 More Information

Veerisetty, Sai S; Eschete, Stephanie O; Uhlhorn, Ann-Porter; De Felice, Kara M (2018. ) Women's Health in Inflammatory Bowel Disease.The American journal of the medical sciences, , 356 (3 ) ,227-233 More Information

De Felice, Kara M; Katzka, David A; Raffals, Laura E (2015. ) Crohn's Disease of the Esophagus: Clinical Features and Treatment Outcomes in the Biologic Era.Inflammatory bowel diseases, , 21 (9 ) ,2106-13 More Information

Gupta, A; De Felice, K M; Loftus, E V; Khanna, S (2015. ) Systematic review: colitis associated with anti-CTLA-4 therapy.Alimentary pharmacology & therapeutics, , 42 (4 ) ,406-17 More Information

De Felice, Kara M; Gupta, Arjun; Rakshit, Sagar; Khanna, Sahil; Kottschade, Lisa A; Finnes, Heidi D; Papadakis, Konstantinos A; Loftus, Edward V; Raffals, Laura E; Markovic, Svetomir N (2015. ) Ipilimumab-induced colitis in patients with metastatic melanoma.Melanoma research, , 25 (4 ) ,321-7 More Information

De Felice, K M; Novotna, M; Enders, F T; Faubion, W A; Tremaine, W J; Kantarci, O H; Raffals, L E (2015. ) Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patients.Alimentary pharmacology & therapeutics, , 41 (1 ) ,99-107 More Information

De Felice, Kara M; Kane, Sunanda V (2014. ) Inflammatory bowel disease in women of reproductive age.Expert review of gastroenterology & hepatology, , 8 (4 ) ,417-25 More Information